Getein Biotech, Inc./ CNE100002RR9 /
24/05/2024 9:00:00 | Diferencia +0.02 | Volumen | Bid9:00:04 | Ask24/05/2024 | Máximo del día | Price Change Band |
---|---|---|---|---|---|---|
9.03CNY | +0.22% | 2.41 millones Volumen de negocios: 21.83 millones |
9.02Volumen de oferta: 2,000 | 9.03Tamaño/ Volumen/ Formato de Ask: 23,600 | 9.12 | 8.98 |
GlobeNewswire
3:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ves...
GlobeNewswire
3:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Per...
GlobeNewswire
3:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hir...
GlobeNewswire
3:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Goo...
GlobeNewswire
3:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Equ...
GlobeNewswire
25/05
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Inari Medical, Inc. Investors to Secure Counsel Before ...
Newsfile Corp
25/05
Retik Finance (RETIK) Launch Completed Successfully, Trading Live On Multiple Exchanges
GlobeNewswire
25/05
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Intel Corporation Investors to Secure Counse...
GlobeNewswire
25/05
Optimum AI: The Future of DeFi, Now Enabled Via Text-Based Trading on WhatsApp and Telegram
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página